Country: কানাডা
ভাষা: ইংরেজি
সূত্র: Health Canada
PROPYLTHIOURACIL
HALEWOOD CHEMICALS LIMITED
H03BA02
PROPYLTHIOURACIL
50MG
TABLET
PROPYLTHIOURACIL 50MG
ORAL
15G/50G
Prescription
ANTITHYROID AGENTS
Active ingredient group (AIG) number: 0103603001; AHFS:
APPROVED
2021-10-06
_Product Monograph Master Template _ _Template date: September 2020 _ _HALYCIL™ (propylthiouracil) _ _Page 1 of 22_ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR HALYCIL™ Propylthiouracil Tablets, 50 mg, Oral BP ATC Code: H03BA02 Thyroid therapy Halewood Chemicals Ltd. Staines, Middlesex, TW19 6BJ United Kingdom www.halewoodchemicals.com Distributed by: Accelera Pharma Canada Inc. Mississauga, ON L5L 5Z9 http://apcipharma.com/ Date of Initial Authorization: OCT 06, 2021 Submission Control Number: 244881 _ _ _Product Monograph Master Template _ _Template date: September 2020 _ _HALYCIL™ (propylthiouracil) _ _Page 2 of 22_ RECENT MAJOR LABEL CHANGES N/A TABLE OF CONTENTS RECENT MAJOR LABEL CHANGES .................................................................................... 2 TABLE OF CONTENTS ......................................................................................................... 2 PART I: HEALTH PROFESSIONAL INFORMATION.............................................................. 4 1 INDICATIONS............................................................................................................. 4 1.1 Pediatrics .......................................................................................................... 4 1.2 Geriatrics........................................................................................................... 4 2 CONTRAINDICATIONS .............................................................................................. 4 3 SERIOUS WARNINGS AND PRECAUTIONS BOX..................................................... 4 4 DOSAGE AND ADMINISTRATION ............................................................................. 5 4.1 Dosing Considerations ....................................................................................... 5 4.2 Recommended Dose and Dosage Adjustment ................................................... 5 4.4 Administration................................................................................. সম্পূর্ণ নথি পড়ুন